Drug-related deaths in a Department of Internal Medicine

Archives of Internal Medicine

Volumn 161, Issue 19, 2001, Pages 2317-2323

  Ebbesen, J ^a   Buajordet, I ^a   Erikssen, J ^a   Brors O ^a   Hilberg, T ^a   Svaar, H ^a   Sandvik, L ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANXIOLYTIC AGENT; CARDIOVASCULAR AGENT; DRUG; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; AUTOPSY; BLEEDING; BONE MARROW DEPRESSION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DRUG FATALITY; DRUG RESPONSE; FEMALE; HEPATORENAL SYNDROME; HOSPITAL DEPARTMENT; HUMAN; INTERNAL MEDICINE; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NORWAY; PANCREATITIS; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RISK FACTOR; SEDATION;

EID: 0035935063     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.19.2317     Document Type: Article

References (43)

1. Incidence of adverse drug events and potential adverse drug events: Implications for prevention
2. Systematic analysis of in-patients' circumstances and causes of death: A tool to improve quality of care
3. Frequency, reporting and classification of drug-related deaths
4. Drug-associated deaths of medical inpatients
5. Drug consumption and adverse reactions in a department of internal medicine
6. Drug-related deaths among medical inpatients
7. Putting adverse drug events into perspective
8. The costs of adverse drug events in hospitalized patients
9. Drugs and adverse drug reactions: How worried should we be
10. Drugs and adverse reactions: An economic view of a medical problem
11. Counting the costs of drug-related adverse events
12. The nature of adverse events in hospitalized patients: Results of the Harvard Medical Practice Study II
13. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
14. Drugs as a cause of death: A prospective quality assurance project in a department of medicine
15. International drug monitoring: The role of national centres
16. Relationship between medication errors and adverse drug events
17. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients: A comment
18. Adverse drug reactions and death: A review of 827 cases
19. Interrater agreement
20. Clinical trials
21. Adverse drug reactions in a surgical department
22. Fatal drug reactions among medical inpatients
23. The ambiguity of adverse drug reactions
24. An algorithm for the operational assessment of adverse drug reactions. I: Background, description, and instructions for use
25. A method for estimating the probability of adverse drug reactions
26. Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population
27. The epidemiology of serious adverse drug reactions among the elderly
28. Adverse drug reactions: An overview of special considerations in the management of the elderly patient
29. An overview of adverse drug reactions
30. Predicting mortality and length of stay of geriatric patients in an acute care general hospital
31. Incidence and types of preventable adverse events in elderly patients: Population based review of medical records
32. A comparison of drug interaction software programs: Applicability to the emergency department
33. Computerized surveillance of adverse drug reactions in hospital: Implementation
34. A computer alert system to prevent injury from adverse drug events: Development and evaluation in a community teaching hospital
35. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals
36. Patient risk factors for adverse drug events in hospitalized patients
37. Ways to minimize adverse drug reactions: Individualized doses and common sense are key
38. Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units
39. Systems analysis of adverse drug events
40. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients